Current position:Home >Product >
Ferrate(4-),hexakis(cyano-kC)-,iron(2+) potassium (1:1:2), (OC-6-11)-
Ferrate(4-),hexakis(cyano-kC)-,iron(2+) potassium (1:1:2), (OC-6-11)-(15362-86-4)
- Name: Ferrate(4-),hexakis(cyano-kC)-,iron(2+) potassium (1:1:2), (OC-6-11)-
- Synonyms:Ferrate(4-),hexacyano-, iron(2+) dipotassium (8CI); Ferrate(4-), hexakis(cyano-C)-,iron(2+) potassium (1:1:2), (OC-6-11)-; Iron potassium ferrocyanide(K2Fe[Fe(CN)6]) (6CI); Everitts Salt; Everitt's salt; Iron(2+) dipotassiumhexacyanoferrate(4-)
- Molecular Formula:C6Fe N6 . Fe . 2 K
- Molecular Weight:345.997
- CAS Registry Number:15362-86-4
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 91771-91-4/Fatty acids, peanut-oil, ammonium salts
- 95159-11-8/N-benzyl-2-(4-chlorophenoxy)-N-[3-(diethylamino)propyl]acetamide
- 222527-66-4/Cyclo(L-isoleucyl-S-oxido-L-methionyl-L-leucyl-L-leucyl-L-prolyl-L-phenylalanyl-L-phenylalanyl-L-tryptophyl)
- 133762-99-9/N-{2-chloro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)-3,6-dihydropyrimidin-1(2H)-yl]phenyl}methanesulfonamide
- 74261-65-7/4-AZIDOPHENYL ISOTHIOCYANATE
- 68081-91-4/Poly(oxy-1,2-ethanediyl), .alpha.-sulfo-.omega.-hydroxy-, C12-18-alkyl ethers, sodium salts
- 153237-23-1/6-desoxy-6-n-octylamino-1,2-3,4-di-O-isopropylidenegalactopyranose
- 73355-65-4/1-benzyl-3-butyl-1-methylurea
- 3566-52-7/2-amino-4-methyl-pent-4-enoic acid
- 115374-34-0/2-Pentenoic acid,3-methyl-5-[(4aS,8aS)-3,4,4a,5,6,7,8,8a-octahydro-2,5,5,8a-tetramethyl-3-oxo-1-naphthalenyl]-,(2Z)-
- 97259-63-7/2,2'-[[3-[2-(dodecyloxy)ethoxy]propyl]imino]bisethanol
- 85567-60-8/1,3-Bis(2,-dimethylphenoxy)propan-2-ol
- 68188-01-2/Quaternary ammonium compounds, (hydrogenated tallow alkyl)bis(hydroxyethyl)methyl, ethoxylated, chlorides
- 94266-42-9/Juniper, Juniperus mexicana, ext., propionate
- 93572-10-2/Fatty acids, peanut-oil, tetrahydrofurfuryl esters
- 369-35-7/2-Fluoro-4-nitroaniline
- 161511-79-1/6H-2,8b-Epoxyoxireno[6,7]azuleno[5,4-e]-1,3-benzodioxol-6-one,3a,3b,3c,4a,5,5a,8a,9,10,10a-decahydro-5,5a-dihydroxy-4a-(hydroxymethyl)-7,9-dimethyl-10a-(1-methylethenyl)-2-[(1E,3E)-1,3,5,7-pentadecatetraenyl]-,(2S,3aR,3bS,3cS,4aR,5S,5aS,8aR,8bR,9R,10aR)- (9CI)
- 5666-17-1/N,N-DIETHYLALLYLAMINE
- 2960-80-7/gona-1(10),2,4,6,8(14),9(11),12-heptaen-12-amine hydrochloride
- 15362-86-4/Ferrate(4-),hexakis(cyano-kC)-,iron(2+) potassium (1:1:2), (OC-6-11)-
- 655-14-1/2,5-difluoroterephthalic acid
- 7460-67-5/1,3,5-trichloro-2-[2-(2-iodoethoxy)ethoxy]benzene
- 23359-08-2/4-Formylcinnamic acid
- 101516-94-3/Gentamicin C, 5-deoxy-(9CI)
- 63916-68-7/3-(2-Methylpiperidino)propyl=p-butoxybenzoate
- 139207-46-8/2-[4-[(E)-[3-[[(2-methylphenyl)amino]methyl]-4-oxo-2-sulfanylidene-thiazolidin-5-ylidene]methyl]phenoxy]-N-[1-(4-methylphenyl)ethylideneamino]acetamide
- 7061-49-6/2-[(2-chlorophenyl)methylidene]-7-methyl-N-(2-methylphenyl)-3-oxo-5-thiophen-2-yl-2,3-dihydro-5H-[1,3]thiazolo[3,2-a]pyrimidine-6-carboxamide
- 102585-05-7/9H-Xanthene-9-carboxylicacid, 1-methyl-4-piperidinyl ester
- 70233-75-9/dihydro-
- 81928-44-1/butan-2-yl(oxo)phenylstannane